TW222592B - - Google Patents

Info

Publication number
TW222592B
TW222592B TW080105645A TW80105645A TW222592B TW 222592 B TW222592 B TW 222592B TW 080105645 A TW080105645 A TW 080105645A TW 80105645 A TW80105645 A TW 80105645A TW 222592 B TW222592 B TW 222592B
Authority
TW
Taiwan
Application number
TW080105645A
Original Assignee
Ss Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ss Seiyaku Kk filed Critical Ss Seiyaku Kk
Application granted granted Critical
Publication of TW222592B publication Critical patent/TW222592B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
TW080105645A 1990-07-25 1991-07-20 TW222592B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2197019A JP2572673B2 (ja) 1990-07-25 1990-07-25 徐放性錠剤

Publications (1)

Publication Number Publication Date
TW222592B true TW222592B (zh) 1994-04-21

Family

ID=16367420

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080105645A TW222592B (zh) 1990-07-25 1991-07-20

Country Status (8)

Country Link
US (1) US5164193A (zh)
EP (1) EP0468436B1 (zh)
JP (1) JP2572673B2 (zh)
KR (1) KR0169319B1 (zh)
CA (1) CA2046845C (zh)
DE (1) DE69128569T2 (zh)
ES (1) ES2111547T3 (zh)
TW (1) TW222592B (zh)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
CA2216215A1 (en) 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
FR2771291B1 (fr) * 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
KR100844295B1 (ko) * 1999-06-04 2008-07-07 알자 코포레이션 이식성 겔 조성물 및 이의 제조방법
JP2003508420A (ja) 1999-09-02 2003-03-04 ノストラム・ファーマスーティカルズ・インコーポレイテッド 経口投与に適した、制御された放出の経口用量
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
WO2002067905A1 (en) * 2001-02-27 2002-09-06 Kos Pharmaceuticals, Inc. A sustained release pharmaceutical formulation
KR100464592B1 (ko) * 2001-04-13 2004-12-31 주식회사 한국팜비오 포타슘시트레이트를 함유한 왁스 매트릭스 타입의 정제와그의 조성물
US9820982B2 (en) 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
US20050031686A1 (en) * 2002-03-25 2005-02-10 Truffini & Regge' Farmaceutici Srl Gastroresistant tablets for alimentary, dietetic and therapeutic use
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
US20050220877A1 (en) * 2004-03-31 2005-10-06 Patel Ashish A Bilayer tablet comprising an antihistamine and a decongestant
AU2005320547B2 (en) 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090060993A1 (en) * 2007-09-04 2009-03-05 Joseph Schwarz Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones
JP5122380B2 (ja) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 薬物の放出を制御した速崩錠及びその製法
US8962020B2 (en) * 2012-07-26 2015-02-24 Glycadia Inc. Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid
US10463699B2 (en) 2016-04-04 2019-11-05 Omeza LLC Fish oil topical composition
MX2020005517A (es) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Formas cristalinas y metodos de produccion de las mismas.
CN112118838A (zh) 2017-12-05 2020-12-22 赛诺维信制药公司 非外消旋混合物及其用途
JP2022535893A (ja) 2019-06-04 2022-08-10 サノビオン ファーマシューティカルズ インク 放出調節製剤およびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione

Also Published As

Publication number Publication date
DE69128569T2 (de) 1998-04-16
KR0169319B1 (ko) 1999-01-15
JP2572673B2 (ja) 1997-01-16
ES2111547T3 (es) 1998-03-16
JPH0482825A (ja) 1992-03-16
CA2046845C (en) 2001-03-27
EP0468436A1 (en) 1992-01-29
DE69128569D1 (de) 1998-02-12
EP0468436B1 (en) 1998-01-07
US5164193A (en) 1992-11-17
KR930001899A (ko) 1993-02-22
CA2046845A1 (en) 1992-01-26

Similar Documents

Publication Publication Date Title
TW222592B (zh)
DE4092522T (zh)
DE4190445T (zh)
DE9001279U1 (zh)
DE9002393U1 (zh)
DE9001134U1 (zh)
DE9003507U1 (zh)
DE9002925U1 (zh)
DE9004940U1 (zh)
DE9004477U1 (zh)
DE9003849U1 (zh)
DE9001343U1 (zh)
DE9000256U1 (zh)
DE9002853U1 (zh)
DE9002922U1 (zh)
DE9000470U1 (zh)
DE9003407U1 (zh)
DE9004005U1 (zh)
DE9003801U1 (zh)
DE9000210U1 (zh)
DE9001354U1 (zh)
DE9000167U1 (zh)
DE9002355U1 (zh)
DE9001735U1 (zh)
DE9001885U1 (zh)